How corporate involvement in psychedelic research could threaten public safety
(Version anglaise seulement)
par Elena Koning, PhD Candidate, Centre for Neuroscience Studies, Queen's University, Ontario
Elisa Brietzke, Professor, Department of Psychiatry, Queen's University, Ontario
Marco Solmi, Associate Professor Department of Psychiatry, L’Université d’Ottawa/University of Ottawa
Substantial economic growth in the psychedelic drugs market has drawn interest from corporations and start-ups. While this may accelerate research, it also sparks concerns about conflicts of interest.
Lire l'article complet
© La Conversation
-
lundi 22 avril 2024